FY25 Half Year Results

In the first half of FY25, Integrated Research (ASX:IRI) reported new business growth of 76% to $7.6m compared to the prior corresponding period. Total Contract Value (TCV) and statutory revenue were down 36% to $26.5m and 29% to $28.8m respectively due to softer renewals book. EBITDA decreased by 58% to $4.6m. Pro forma revenue remained steady, while a new product was released, and a major US bank signed on. Despite the decline in revenue and EBITDA, the company's balance sheet remains strong with $31.1 million in net cash as of December 2024. The focus for the second half of FY25 is on the execution of the product-led growth strategy, including investing in innovation, growing the sales pipeline, and transitioning to sustainable growth. The CEO, Ian Lowe, highlighted early progress against the growth strategy and expressed confidence in the Company's ability to deliver sustained growth. With new product momentum building, Integrated Research expects to make further announcements in the coming months. Investors are encouraged to inquire about the Company's financial performance, strategic initiatives, and future plans via the investor hub.